The market rallied today with the NASDAQ up 1.48 % and the S&P up 1.26%. The leading sectors today were capital goods , materials and energy. Biotechs overall were up only 0.8% but were much better even though our mid-cap index was up only 0.49%. Within the Rayno Life Science Portfolio big winners were Biogen (BIIB) up 3.38%, Exelixis(EXEL) up 4.51%, and Regeneron (REGN)up 2%.
In Tools and Diagnostics Abaxis (ABAX), Cardiovascular Sciences(CSII) up 2.23%, ExactSciences (EXAS) up 2.9% and Illumina(ILMN) up 1.53%.
Leerink Swann analyst Dan Leonard wrote a positive note for the Life Science tools sector based upon commentary on Japan from Shimadzu. Leerink reiterated their outperform on ASLR,CALP,FLDM,ILMN,LIFE,SIAL,TMO and WAT.